|Videos|April 29, 2023

AI:‘The Future is Actually Already Here for Clinicians’

Artificial intelligence (AI) is being utilized already says one clinician. She explains her optimism about the technology, and says it will help augment any potential challenges providers have now or in the future.


“Clinicians are already using AI; the problem is they don’t know they are using AI,” states Deepti Pandita, MD, FACP, FAMIA, chief medical information officer, University of California Irvine. “Your EMR may be presenting you with a lot of clinical support tools that behind the scenes are driven by AI. They have machine learning algorithms that are constantly working.”

Pandita presented a scientific session, Artificial Intelligence/Machine Learning: Practical Applications in Medicine, at this week’s ACP conference being held in San Diego.

With the enormous amount of responsibilities that providers have including remembering patient information, paperwork, increasing workloads at institutions, Pandita sees the potential to alleviate the need to remember everything. “AI helps with reducing the cognitive burden.”

The concern, Pandita says, is if the AI is set up to address individual patients. “The question is, we don’t know if whether those AI algorithms are configured in a manner that are truly safe for your patient population, and how do you build confidence in those?”

As with all evolving technologies it remains to be seen what the intended and unintended consequences will be, but Pandita is confident human physicians and other providers will not be replaced. “I think the human brain surpasses anything AI can do.”

She sees it as artificial augmentation and not artificial intelligence. “You are augmenting what the human brain can do and adding artificial intelligence to it…think of it as a helper in the clinical setting.”

She uses the example of how AI, specifically chatbots, can now help with writing notes and possibly interactions with patients in showing more empathy. This last concept was shown in a new study published in JAMA Internal Medicine, which demonstrated that chatbot responses were preferred over physicians’ responses in a social media forum where patients’ questions were posted.

Contagion spoke to Panditia about some of the ideas we can expect going forward with this emerging technology, such as writing scientific papers, and the need for trust-building with AI as it will only become increasingly omnipresent.


Related to this article

Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
ID Week Highlights Part 1
In this first IDWeek 2026 roundup, oral olorofim matched AmBisome in invasive aspergillosis, aztreonam-avibactam held activity as MBL-producing CRE rose, pritelivir cut hospitalizations in refractory HSV, and zelicapavir shortened RSV symptoms in high-risk adults.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.